(a) Ketosis |
(i) Hyperpolarization of neurons by Potassium channel activation |
(ii) Slow energy production (compared to pathway wherein energy is derived primarily from glucose) which leads to anti-seizure effects |
(iii) Potentiation of inhibitory neurotransmitters (eg, GABA) |
(iv) Augmented neuronal function through cellular |
(v) Chronic ketosis is postulated to stabilize and reduce synaptic hyperexcitability in order to conserve energy, thereby increasing seizure threshold |
(b) Increased levels of Polyunsaturated Fatty Acids (PUFA) |
(i) Activation of e peroxisome proliferator-activated receptors (PPARs) |
(ii) Hyperpolarization of neurons |
(c) Alteration of gut microbiome |
Possible role in increasing seizure threshold due to putative microorganisms (eg, Akkermansiamuciniphila and Parabacteroides) which has been noted in murine models as well as human studies of gut microbiome |
(d) Alteration of proinflammatory and anti-inflammatory mediators |
Reduced levels of Interleukin 1b and other proinflammatory cytokines in mice treated with KD supports the role of modulation of these inflammatory mediators in combating epilepsy |